Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Novo Nordisk A/S Class B (NOVOb)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
942.4 -0.6    -0.06%
01/02 - Closed. Currency in DKK ( Disclaimer )
Type:  Equity
Market:  Denmark
ISIN:  DK0060534915 
S/N:  1742564000
  • Volume: 3,209,775
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 926.3 - 971.0
Novo Nordisk B 942.4 -0.6 -0.06%

Novo Nordisk B is a component of the following Indices

 
See which major and sector indices this stock is a component of.
Create Alert
Add to Watchlist
Add to/Remove from Watchlist  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

 IndexLastHighLowChg.Chg. %Time
 Low Carbon 100 Europe146.05146.93145.79-0.25-0.17%01/02 
 OMX Nordic 402,233.272,249.642,229.06+9.68+0.44%01/02 
 OMX Copenhagen All shares2,525.582,552.942,510.35+20.17+0.81%01/02 
 OMX Copenhagen Benchmark2,925.392,965.342,905.55+18.40+0.63%01/02 
 OMXC201,845.921,874.231,831.95+11.39+0.62%01/02 
 Copenhagen Benchmark Cap GI2,326.512,335.932,312.98+25.23+1.10%01/02 
 OMX Copenhagen Cap GI2,525.792,534.772,508.95+29.80+1.19%01/02 
 Copenhagen Cap PI1,397.801,402.771,388.48+16.50+1.19%01/02 
 Pharma & Biotechnology PI6,234.366,234.366,234.36-3.81-0.06%01/02 
 Copenhagen Health Care5,881.756,001.975,810.94+14.25+0.24%01/02 
 OMX Copenhagen All shares PI1,406.631,421.871,398.15+11.23+0.80%01/02 
 STOXX 600453.08453.08453.080.000.00%20:00:13 
 MSCI Pan Euro1,408.361,415.861,405.27-2.02-0.14%01/02 
 Low Carbon 100 EUR Net223.75225.08223.35-0.38-0.17%01/02 
 STXE 50 Nrt9,575.009,645.809,552.68-40.59-0.42%01/02 
 STXE Health Care PR986.241,005.16985.780.000.00%11:50:00 
 STXE Health Care NR1,873.191,909.131,872.31-23.26-1.23%01/02 
 STOXX Europe 50 EUR Price3,837.063,865.433,828.11-16.26-0.42%01/02 
 STOXX Europe Large 200 EUR Price464.11466.61463.08-0.51-0.11%01/02 
 DJ Health Care Titans 30932.68932.95932.30+2.05+0.22%01:20:00 
 DJ Sector Titans Composite534.80535.08534.63+1.31+0.24%01:20:00 
 NQ OMX Nordic 1201,376.061,384.931,371.97+0.00+0.00%11:35:00 
 NQ OMX Nordic Health Care3,495.183,540.603,487.23+0.00+0.00%11:35:00 
 OMX Copenhagen Benchmark Cap PI1,325.801,331.171,318.09+14.38+1.10%01/02 
 OMX Copenhagen Benchmark PI1,646.441,668.921,635.27+10.36+0.63%01/02 
 OMX Copenhagen Large Cap PI425.83430.58423.25+3.44+0.81%01/02 
 OMX Nordic Large Cap DKK PI400.14402.28398.35+0.00+0.00%11:35:00 
 OMX Nordic Large Cap EUR PI399.41401.59397.65+0.00+0.00%11:35:00 
 OMX Nordic Large Cap ISK PI Equity314.05315.90312.18+0.00+0.00%11:35:00 
 OMX Nordic Large Cap SEK PI496.32498.25493.18+0.00+0.00%11:35:00 
 Low Carbon 100 Europe GTR246.71248.18246.27-0.42-0.17%01/02 
 STOXX Europe Large 200 NR1,102.501,102.501,102.50-1.21-0.11%00:00:00 
 STOXX Europe 50 Price3,129.763,141.033,119.86+4.29+0.14%01/02 
 STOXX Europe 50 NR7,805.907,805.907,805.90+10.70+0.14%01/02 
 STOXX Nordic 30 EUR Price12,691.7612,773.7012,666.87+52.83+0.42%01/02 
 STOXX Nordic 30 USD Price10,292.9810,292.9810,292.98+100.10+0.98%01/02 
 STOXX Global 150 EUR Price5,811.275,811.555,737.46+18.07+0.31%01/02 
 STOXX All Europe 100 EUR Price1,424.101,432.751,420.94-3.60-0.25%01/02 
 NOMX Nordic Healthcare Net4,398.964,456.134,388.95+3.07+0.07%01/02 
 NOMX Nordic 120 Net1,911.851,924.171,906.16+10.26+0.54%01/02 
 OMX Nordic EUR PI439.69442.01437.73+3.25+0.74%01/02 
 OMX Nordic All-Share ISK PI Equity321.88323.75319.94+3.24+1.02%01/02 
 OMX Nordic SEK PI546.38548.42542.89+4.45+0.82%01/02 
 OMXC251,716.891,727.071,707.59+18.47+1.09%01/02 
 OMX Nordic Large Cap DKK GI354.68356.58353.10+2.67+0.76%01/02 
 OMX Nordic Large Cap EUR GI355.50357.44353.94+2.64+0.75%01/02 
 OMX Nordic Large Cap ISK GI Equity524.76527.86521.64+5.30+1.02%01/02 
 OMX Nordic Large Cap SEK GI435.71437.41432.96+3.56+0.82%01/02 
 OMX Nordic DKK GI359.75361.60358.11+2.71+0.76%01/02 
 OMX Nordic DKK PI440.50442.77438.50+3.31+0.76%01/02 
 OMX Nordic EUR GI360.57362.47358.96+2.67+0.75%01/02 
 OMX Nordic All-Share ISK GI Equity531.41534.49528.21+5.35+1.02%01/02 
 OMX Nordic SEK GI441.93443.58439.10+3.60+0.82%01/02 
 NOMXN120GI2,037.232,050.362,031.17+10.94+0.54%01/02 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVOb Comments

Write your thoughts about Novo Nordisk A/S Class B
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Terrible Investor
TerribleInvestor Jan 03, 2023 11:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very very bullish!
Toby Brunt
Toby Brunt Apr 19, 2022 5:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Does anyone no of a particular reason that NOVO B is going so far down today? Is it profit taking before Q1 2022 results?
Sandy SS
Sandy SS Feb 09, 2022 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
New Target 825 by EOM
Sandy SS
Sandy SS Feb 09, 2022 8:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
New Target 825
Terrible Investor
TerribleInvestor Nov 25, 2021 5:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Consolidating nicely for leg up to 850!🌟
Ralf Adams
Ralf Adams Feb 11, 2021 4:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Results from clinical study just published in New England Journal of Medicine: Impressive new weight loss results for Semaglutide at only 2.4 mg once a week. Drug mimics the gut hormone glucagon-like peptide-1 (GLP-1) that is secreted by your gut after eating.
Candy Man
Candy Man Jan 14, 2021 4:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now is the time to buy - novo is very seasonal stock goes up the most in jan/feb.
Carlos Andres
Carlos Andres Aug 25, 2020 4:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bullish??
Carlos Andres
Carlos Andres Aug 25, 2020 4:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No. Funds are selling. Time to wait to go long...
White Wizard
White Wizard May 26, 2020 7:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Perfect opportunity to make short,,
Wassim Khayata
Wassim Khayata May 26, 2020 7:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
can you explain why please?
Jeff Heimann
Jeff Heimann May 26, 2020 7:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No explaning? 🤷
Tommi Nuutinen
Tommi Nuutinen May 26, 2020 7:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
because he has no explanation. Novo nordisk is a soli long-term stock. I know a lot about opioid treatments, and methadon is changing to lipo-methadon, wich has really only one competitor on the global field. That competitor is Camurus AB with their product buvidol. I tecommend to all investors to buy and HOLD for these two companies, because there is no other options for a opioid-replacement-care, except Suboxone, and that is going to be replaced Lipo-methadon or Buvidol, at least here in Finland. Suboxone is manufactured for Indivor Inc, by Aquestive Therapeutics, if someone wants to do a little research.
Hairol Azhar Abdul Kadir
Hairol Azhar Abdul Kadir Jan 19, 2020 2:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bullish sentiment.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email